F.R. Pruvot

1.8k total citations
19 papers, 674 citations indexed

About

F.R. Pruvot is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, F.R. Pruvot has authored 19 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Hepatology and 6 papers in Oncology. Recurrent topics in F.R. Pruvot's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). F.R. Pruvot is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). F.R. Pruvot collaborates with scholars based in France, Belgium and United States. F.R. Pruvot's co-authors include Stéphanie Truant, Gilles Lebuffe, Philippe Mathurin, Sébastien Dharancy, M Steinling, Olivier Ernst, Mohamed Hebbar, D. Huglo, Emmanuel Boleslawski and Julia Salleron and has published in prestigious journals such as Journal of Hepatology, British Journal of Cancer and British journal of surgery.

In The Last Decade

F.R. Pruvot

19 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.R. Pruvot France 11 360 337 249 155 96 19 674
Eva Montalvá Spain 13 443 1.2× 457 1.4× 170 0.7× 112 0.7× 18 0.2× 65 706
Frederick Ryckman United States 14 217 0.6× 450 1.3× 73 0.3× 99 0.6× 16 0.2× 28 608
Jinsoo Rhu South Korea 15 488 1.4× 610 1.8× 151 0.6× 125 0.8× 42 0.4× 111 843
Y. Hamashima Japan 13 213 0.6× 358 1.1× 104 0.4× 79 0.5× 13 0.1× 52 541
B Descottes France 12 414 1.1× 680 2.0× 69 0.3× 358 2.3× 47 0.5× 77 950
C. E. Broelsch Germany 13 185 0.5× 315 0.9× 378 1.5× 240 1.5× 14 0.1× 41 773
Shiobhan R. Weston United States 11 419 1.2× 346 1.0× 665 2.7× 58 0.4× 82 0.9× 18 1.0k
Wulf Euringer Germany 20 344 1.0× 532 1.6× 452 1.8× 85 0.5× 270 2.8× 30 1.0k
Chee‐Chien Yong Taiwan 17 747 2.1× 673 2.0× 309 1.2× 143 0.9× 14 0.1× 103 977
Andrea Pisani Ceretti Italy 13 116 0.3× 274 0.8× 72 0.3× 224 1.4× 50 0.5× 27 447

Countries citing papers authored by F.R. Pruvot

Since Specialization
Citations

This map shows the geographic impact of F.R. Pruvot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.R. Pruvot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.R. Pruvot more than expected).

Fields of papers citing papers by F.R. Pruvot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.R. Pruvot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.R. Pruvot. The network helps show where F.R. Pruvot may publish in the future.

Co-authorship network of co-authors of F.R. Pruvot

This figure shows the co-authorship network connecting the top 25 collaborators of F.R. Pruvot. A scholar is included among the top collaborators of F.R. Pruvot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.R. Pruvot. F.R. Pruvot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Truant, Stéphanie, Olivier Scatton, Safi Dokmak, et al.. (2015). Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Impact of the inter-stages course on morbi-mortality and implications for management. European Journal of Surgical Oncology. 41(5). 674–682. 105 indexed citations
2.
Boleslawski, Emmanuel, Stéphanie Truant, Sébastien Dharancy, et al.. (2012). Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis. British journal of surgery. 99(6). 855–863. 118 indexed citations
3.
Levy, Gary, S. Cattan, Géraldine Sergent, et al.. (2011). 626 ASSESSMENT OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: PROGNOSTIC VALUE OF TUMORAL DENSITY AND ARTERIAL ENHANCEMENT MEASUREMENTS IN TARGET LESIONS. Journal of Hepatology. 54. S254–S254. 1 indexed citations
4.
Zerbib, Philippe, Stéphanie Truant, Ahmed Bouras, et al.. (2010). Pre‐operative management is associated with low rate of post‐operative morbidity in penetrating Crohn’s disease. Alimentary Pharmacology & Therapeutics. 32(3). 459–465. 61 indexed citations
5.
Boleslawski, Emmanuel, Sébastien Dharancy, Stéphanie Truant, & F.R. Pruvot. (2010). Surgical management of liver metastases from gastrointestinal endocrine tumors. Gastroentérologie Clinique et Biologique. 34(4-5). 274–282. 2 indexed citations
6.
Castel, Hélène, Carolina Moreno, Térésa Antonini, et al.. (2010). 29 EARLY TRANSPLANTATION IMPROVES SURVIVAL OF NON-RESPONDERS TO CORTICOSTEROIDS IN SEVERE ALCOHOLIC HEPATITIS: A CHALLENGE TO THE 6 MONTH RULE OF ABSTINENCE. Journal of Hepatology. 52. S13–S13. 14 indexed citations
7.
Cattan, S., Sébastien Dharancy, V. Canva, et al.. (2009). 66 PROSPECTIVE EVALUATION OF SORAFENIB (SO) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): DOES CHILD SCORE B INFLUENCE SAFETY?. Journal of Hepatology. 50. S28–S28. 1 indexed citations
8.
Fleyfel, M., B. Tavernier, Éric Kipnis, et al.. (2006). Non-invasive prediction of fluid responsiveness during major hepatic surgery † ‡. British Journal of Anaesthesia. 97(6). 808–816. 111 indexed citations
9.
Truant, Stéphanie, D. Huglo, Mohamed Hebbar, et al.. (2005). Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d-glucose positron emission tomography of resectable colorectal liver metastases. British journal of surgery. 92(3). 362–369. 84 indexed citations
10.
Karoui, Mehdi, Christophe Trésallet, C. Julié, et al.. (2004). Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. British Journal of Cancer. 90(6). 1230–1234. 20 indexed citations
11.
Mathurin, Philippe, Bruno Raynard, Sébastien Dharancy, et al.. (2003). Meta‐analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 17(10). 1247–1261. 85 indexed citations
13.
Hazzan, Marc, et al.. (1997). Comparative study of chronic ambulatory peritoneal dialysis versus hemodialysis patients after kidney transplantation: Clinical and financial assessment. Transplantation Proceedings. 29(5). 2428–2428. 14 indexed citations
14.
Noël, C., et al.. (1997). Indication for allograft nephrectomy after irreversible rejection: Is there an ideal delay?. Transplantation Proceedings. 29(1-2). 145–146. 15 indexed citations
15.
Hazzan, Marc, et al.. (1997). Lung granulomatous pneumocystosis after kidney transplantation: An uncommon complication. Transplantation Proceedings. 29(5). 2409–2409. 10 indexed citations
16.
Delcambre, F., F.R. Pruvot, Ramón M. Pujol, et al.. (1996). Primary bronchogenic carcinoma in transplant recipients.. PubMed. 28(5). 2884–5. 18 indexed citations
17.
Dracon, M, et al.. (1994). [Axillo-axillary access in hemodialysis].. PubMed. 15(2). 175–6. 7 indexed citations
18.
Pruvot, F.R., et al.. (1989). [The lung in brain death. Anatomo-biological correlations for pulmonary transplantation].. PubMed. 18(9). 480–3. 3 indexed citations
19.
Chambón, J. P., M Ribet, P Quandalle, et al.. (1987). [Splenic complications of chronic pancreatitis. Clinical and experimental study].. PubMed. 124(4). 253–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026